1. Home
  2. JILL vs GALT Comparison

JILL vs GALT Comparison

Compare JILL & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J. Jill Inc.

JILL

J. Jill Inc.

HOLD

Current Price

$12.31

Market Cap

188.7M

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$2.51

Market Cap

199.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JILL
GALT
Founded
1959
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.7M
199.2M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
JILL
GALT
Price
$12.31
$2.51
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$17.00
$8.50
AVG Volume (30 Days)
49.8K
277.6K
Earning Date
06-10-2026
05-15-2026
Dividend Yield
2.42%
N/A
EPS Growth
N/A
36.84
EPS
1.82
N/A
Revenue
$596,549,000.00
N/A
Revenue This Year
$2.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.41
$1.22
52 Week High
$18.80
$7.13

Technical Indicators

Market Signals
Indicator
JILL
GALT
Relative Strength Index (RSI) 48.26 56.58
Support Level $12.02 $2.10
Resistance Level $12.71 $2.60
Average True Range (ATR) 0.60 0.18
MACD 0.04 0.05
Stochastic Oscillator 41.86 77.70

Price Performance

Historical Comparison
JILL
GALT

About JILL J. Jill Inc.

J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). J.Jill caters to a distinctive set of women, typically forty-five years and older, offering them various apparel products, footwear, and accessories, comprising shirts, dresses, tops and tees, sweaters, pants and jeans, jewelry, bags, belts, shoes, scarves, etc. The company's operating segments consist of its Retail channels, which derive maximum revenue, and Direct channels. Geographically, the majority of its revenue is derived from the United States.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: